Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513331 · ClinicalTrials.gov registry record
Barrett's Esophagus & Gastroesophageal Reflux Disease
A clinical trial, sponsored by Valley Health System.
- Completed
- Registry status
- 125
- Enrollment target
NCT00513331 is a clinical trial that has completed, run by Valley Health System. The registered enrollment target is 125 participants.
The verdict
NCT00513331 has completed, sponsored by Valley Health System.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
This is a study of Barrett's Esophagus (BE) and Gastroesophageal Reflux Disease (GERD). It aims to look at the long term efficacy of evidence-based cutting edge diagnostic and therapeutic algorithms and techniques such as radiofrequency ablation, endoscopic mucosal resection and surveillance endoscopy with biopsy. Additionally, biological analyses will be performed in hopes of identifying biomarkers associated with the progression of BE to esophageal cancer.
Interventions
- PROCEDURE Endoscopy
- PROCEDURE Radiofrequency ablation protocol
- PROCEDURE Endoscopic mucosal resection protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-07 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513331
The ClinicalTrials.gov registry entry for NCT00513331 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valley Health System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Endoscopy is the first listed.
NCT00513331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00513331 about?
NCT00513331 is a clinical study titled "Barrett's Esophagus & Gastroesophageal Reflux Disease". This is a study of Barrett's Esophagus (BE) and Gastroesophageal Reflux Disease (GERD). It aims to look at the long term efficacy of evidence-based cutting edge diagnostic and therapeutic algorithms and techniques such as radiofrequency ablation, endoscopic mucosal resection and surveillance endosco...
What is the current status of trial NCT00513331?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2007-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00513331?
The interventions under investigation include: Endoscopy (PROCEDURE), Radiofrequency ablation protocol (PROCEDURE), Endoscopic mucosal resection protocol (PROCEDURE).
Who is sponsoring clinical trial NCT00513331?
This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.